NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Azenta, Inc. (AZTA) Stock Analysis

Azenta, Inc. (AZTA) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

AZTA

$36.76

+$1.03 (+2.88%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AZTA with… →

AZTA Key Statistics

As of Oct 21, 2026
Trading
Open
$35.44
Previous Close
$35.73
Day's Range
34.93–37.05
52-Week Range
15.93–46.41
Volume
635.15K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.52
Valuation
Market Cap
$1.57B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
64.67
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.53
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.55
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.47
Financials (FY)
Revenue (FY)
$593.82M+3.55%
Net Income (FY)
−$55.76M
Profit marginThe share of revenue left as profit after all costs and taxes.
−20.02%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
43.81M
1-Year Return
+15.56%
Dividend and dates
Earnings Date
November 20, 2026estimated
Avg Volume
927.43K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, AZTA closed at $36.76, +15.56% over 1 year.

Azenta, Inc. (AZTA) has a market capitalization of $1.57B.

In fiscal 2025, AZTA reported revenue of $593.82M.

AZTA Stock Return by Calendar Year

Azenta, Inc. (AZTA) 10-year return: what $10,000 became

1 year
$10,000 $11,556
+15.56%
5 years
$10,000 $3,431
−65.69%
10 years
$10,000 $29,657
+196.57%

If you had invested $10,000 in Azenta, Inc. (AZTA) 10 years ago, at the close on October 21, 2016, it would have been worth $29,657 at the close on October 21, 2026: +196.57% in total, +11.48% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+10.52%
2025−33.48%
2024−23.24%
2023+11.89%
2022−43.54%
2021+52.62%
2020+63.07%
2019+62.06%
2018+11.20%
2017+42.03%
2016 (partial year)+38.14%

As of October 21, 2026.

AZTA Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025$593.82M−$55.76M−9.4%
2024$573.45M−$164.90M−28.8%
2023$551.49M−$14.64M−2.7%
2022$555.50M$2.13B384.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$593.82M$270.28M−$21.67M−$55.76M−9.4%
2024$573.45M$254.62M−$39.86M−$164.90M−28.8%
2023$551.49M$239.21M−$56.67M−$14.64M−2.7%
2022$555.50M$255.58M−$23.42M$2.13B384.0%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

AZTA Dividend History

$0.40+0.0% vs 2020

Dividends per share, 2021 · 4 payments

YearDividends per sharePaymentsChange
2021$0.404+0.0%
2020$0.404+0.0%
2019$0.404+0.0%
2018$0.404+0.0%
YearDividends per sharePaymentsChange
2021$0.404+0.0%
2020$0.404+0.0%
2019$0.404+0.0%
2018$0.404+0.0%
2017$0.404+300.0%
2016$0.101—

Most recent payment: $0.10 per share, ex-dividend December 2, 2021. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

AZTA Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricAZTAMedical Instruments & Supplies medianvs median
P/S ratio2.552.602% below
Profit margin−20.02%1.62%21.6 pts below

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Azenta, Inc. (AZTA) is capitalised at $1.57B on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 2,900.

The 52-week range on file runs from $15.93 to $46.41. The most recent close on file for AZTA is $36.76, dated October 21, 2026. That is +$1.03 (+2.88%) against the previous close. The latest close sits 130.76% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $593.82M. Against the prior fiscal year total of $573.45M, that is a change of +3.55%. The same year closed with a net loss of $55.76M. The reported profit margin is −20.02%. That is 21.6 percentage points below the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to −2.47.

Across the 4 fiscal years on file, revenue moves from $555.50M in 2022 to $593.82M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. On forward earnings the ratio is 64.67. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.53. Measured against sales, the shares trade at 2.55 times revenue. On price-to-sales that is 1.83% below the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is +15.56%. Across 10 years the annualized return works out at +11.48%. Beta against the wider market is reported at 1.52. Annualized volatility over the trailing 10 years is 52.34%.

Growth & Income

The latest dividend on file for AZTA dates from 2021. Dividends are recorded for 6 calendar years; 2021 shows 4 payments totalling $0.40 a share. The year before, 2020, totalled $0.40 a share.

Across the complete calendar years on file, 2020 returned +63.07% and 2022 returned −43.54%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the total return is +10.52% year to date.

Peer Comparison

Azenta, Inc. (AZTA) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Azenta, Inc. AZTA $1.57B —
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Azenta, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Azenta, Inc.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Visit website →